laser tattoo removal

Skincare Equipment: PicoSure laser

Main Image: 
PicoSure laser

The Cynosure PicoSure laser workstation has received FDA clearance for the removal of tattoos and benign pigmented lesions. In a study by Roy Geronemus, MD, director of the Laser & Skin Surgery Center of New York, PicoSure treatments over a two-week period led to a more than 80% overall tattoo clearance, with 94% clearance for difficult-to-remove blue and green inks. The laser offers an ultra-short pulse duration to break down pigment with fewer treatments and less fluence than nanosecond lasers. Contact: 800.886.2966, www.cynosure.com.

Articles: 

Pliaglis Topical Anesthetic Heads Back To Market

The United States Food & Drug Administration (www.fda.gov) has accepted a supplemental New Drug Application (sNDA) for review for topical local anesthetic cream Pliaglis. The anesthetic—owned by Nuvo Research and distributed in the U.S. exclusively by Galderma Laboratories, originally received FDA approval in June 2006. Galderma voluntarily pulled the product from the market in 2008, due to manufacturing issues that occurred at a third-party manufacturing facility.